[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ClearPath100 ClearPath ClearPath posts on X about $voyg, $qure, point72, pricing the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1896831415054221312/interactions)  - X Week XXX -XX% - X Month XXXXX -XX% ### Mentions: X [#](/creator/twitter::1896831415054221312/posts_active)  ### Followers: XXX [#](/creator/twitter::1896831415054221312/followers)  - X Week XXX +8.50% - X Month XXX +17% ### CreatorRank: undefined [#](/creator/twitter::1896831415054221312/influencer_rank)  ### Social Influence [#](/creator/twitter::1896831415054221312/influence) --- **Social category influence** [finance](/list/finance) **Social topic influence** [$voyg](/topic/$voyg), [$qure](/topic/$qure), [point72](/topic/point72), [pricing](/topic/pricing), [asts](/topic/asts), [rklb](/topic/rklb), [$87b](/topic/$87b), [$2b](/topic/$2b), [$31billion](/topic/$31billion), [investment](/topic/investment) **Top assets mentioned** [Voyager Technologies, Inc. (VOYG)](/topic/$voyg) [Rocket Lab USA, Inc. Common Stock (RKLB)](/topic/$rklb) [AST SpaceMobile, Inc. Class A Common Stock (ASTS)](/topic/$asts) [Bitcoin Incognito (XBI)](/topic/$xbi) ### Top Social Posts [#](/creator/twitter::1896831415054221312/posts) --- Top posts by engagements in the last XX hours "@nanalyzetweets $VOYG will see big ramp up once Starlab is active. There is obviously execution risk to the JV which is why market is pricing Voyager as it does - but this is a great time to get in"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1943625993706426397) 2025-07-11 10:58:42 UTC XXX followers, XXX engagements "$VOYG $RKLB $ASTS Seraphim VC Q2. XX report: SpaceTech investment soared to $XXX billion up from $X b in Q1the 2nd largest ever quarterly total. Trailing12month funding reached $XXX b. XX% of capital went into Series B & C"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1945756231991218687) 2025-07-17 08:03:30 UTC XXX followers, XXX engagements "@matan_flank @RNAiAnalyst Significantly mispriced. Many well-known LS/bio-focused funds (e.g. Vestal Point ex Point72 founding partner) have already built up meaningful positions in $QURE"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1943295510296588422) 2025-07-10 13:05:28 UTC XXX followers, XXX engagements "$XBI $QURE #biotech Ryan Wilder's (ex Point72 PM) Vestal Point Capital yesterday disclosed a XXX% position in UniQure. Strong vote of confidence from a luminary in biotech investments. FDA update on AMT-130 expected shortly. Guggenheim says "binary event with 100%+ upside.""  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1923240655326720114) 2025-05-16 04:54:38 UTC XXX followers, 2534 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ClearPath posts on X about $voyg, $qure, point72, pricing the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance
Social topic influence $voyg, $qure, point72, pricing, asts, rklb, $87b, $2b, $31billion, investment
Top assets mentioned Voyager Technologies, Inc. (VOYG) Rocket Lab USA, Inc. Common Stock (RKLB) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Bitcoin Incognito (XBI)
Top posts by engagements in the last XX hours
"@nanalyzetweets $VOYG will see big ramp up once Starlab is active. There is obviously execution risk to the JV which is why market is pricing Voyager as it does - but this is a great time to get in" @ClearPath100 on X 2025-07-11 10:58:42 UTC XXX followers, XXX engagements
"$VOYG $RKLB $ASTS Seraphim VC Q2. XX report: SpaceTech investment soared to $XXX billion up from $X b in Q1the 2nd largest ever quarterly total. Trailing12month funding reached $XXX b. XX% of capital went into Series B & C" @ClearPath100 on X 2025-07-17 08:03:30 UTC XXX followers, XXX engagements
"@matan_flank @RNAiAnalyst Significantly mispriced. Many well-known LS/bio-focused funds (e.g. Vestal Point ex Point72 founding partner) have already built up meaningful positions in $QURE" @ClearPath100 on X 2025-07-10 13:05:28 UTC XXX followers, XXX engagements
"$XBI $QURE #biotech Ryan Wilder's (ex Point72 PM) Vestal Point Capital yesterday disclosed a XXX% position in UniQure. Strong vote of confidence from a luminary in biotech investments. FDA update on AMT-130 expected shortly. Guggenheim says "binary event with 100%+ upside."" @ClearPath100 on X 2025-05-16 04:54:38 UTC XXX followers, 2534 engagements
/creator/x::ClearPath100